Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Amortization of Deferred Charges: 2017-2024

Historic Amortization of Deferred Charges for Mesa Laboratories (MLAB) over the last 5 years, with Mar 2024 value amounting to $234,000.

  • Mesa Laboratories' Amortization of Deferred Charges rose 2.63% to $234,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $926,000, marking a year-over-year increase of 2.09%. This contributed to the annual value of $990,000 for FY2025, which is 6.91% up from last year.
  • Mesa Laboratories' Amortization of Deferred Charges amounted to $234,000 in Q1 2024, which was up 1.30% from $231,000 recorded in Q4 2023.
  • In the past 5 years, Mesa Laboratories' Amortization of Deferred Charges registered a high of $1.4 million during Q1 2021, and its lowest value of $221,000 during Q2 2021.
  • In the last 3 years, Mesa Laboratories' Amortization of Deferred Charges had a median value of $228,000 in 2023 and averaged $228,667.
  • As far as peak fluctuations go, Mesa Laboratories' Amortization of Deferred Charges grew by 4.71% in 2020, and later tumbled by 83.61% in 2022.
  • Mesa Laboratories' Amortization of Deferred Charges (Quarterly) stood at $1.4 million in 2020, then slumped by 73.40% to $361,000 in 2021, then slumped by 37.12% to $227,000 in 2022, then grew by 1.76% to $231,000 in 2023, then climbed by 2.63% to $234,000 in 2024.
  • Its Amortization of Deferred Charges stands at $234,000 for Q1 2024, versus $231,000 for Q4 2023 and $231,000 for Q3 2023.